Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Documenti analoghi

• VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease
  di: Eikenboom, Jeroen, et al.
  Pubblicazione: (2013)
• Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort
  di: Hampshire, Daniel J., et al.
  Pubblicazione: (2010)
• von Willebrand Factor Variant p.Arg924Gln Marks an Allele Associated with Reduced von Willebrand Factor and Factor VIII Levels
  di: HICKSON, N., et al.
  Pubblicazione: (2010)
• The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF
  di: Haberichter, Sandra L., et al.
  Pubblicazione: (2010)
• Principles of care for the diagnosis and treatment of von Willebrand disease
  di: Castaman, Giancarlo, et al.
  Pubblicazione: (2013)